Trial Profile
Proof-of-Concept Study of IVIg Efficacy in Patients With Cutaneous Lupus Erythematosus
Status:
Completed
Phase of Trial:
Phase 0
Latest Information Update: 20 Mar 2018
Price :
$35
*
At a glance
- Drugs Immune globulin (Primary) ; Immunosuppressants
- Indications Cutaneous lupus erythematosus
- Focus Proof of concept; Therapeutic Use
- 07 Aug 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 07 May 2013 New trial record